BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29644394)

  • 21. Independent molecular development of metachronous glioblastomas with extended intervening recurrence-free interval.
    Martinez R; Schackert HK; von Kannen S; Lichter P; Joos S; Schackert G
    Brain Pathol; 2003 Oct; 13(4):598-607. PubMed ID: 14655763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhabdoid glioblastoma is distinguishable from classical glioblastoma by cytogenetics and molecular genetics.
    Byeon SJ; Cho HJ; Baek HW; Park CK; Choi SH; Kim SH; Kim HK; Park SH
    Hum Pathol; 2014 Mar; 45(3):611-20. PubMed ID: 24457079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma.
    Vortmeyer AO; Stavrou T; Selby D; Li G; Weil RJ; Park WS; Moon YW; Chandra R; Goldstein AM; Zhuang Z
    Cancer; 1999 Jun; 85(12):2662-7. PubMed ID: 10375116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary and secondary glioblastomas: from concept to clinical diagnosis.
    Kleihues P; Ohgaki H
    Neuro Oncol; 1999 Jan; 1(1):44-51. PubMed ID: 11550301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma.
    Riehmer V; Gietzelt J; Beyer U; Hentschel B; Westphal M; Schackert G; Sabel MC; Radlwimmer B; Pietsch T; Reifenberger G; Weller M; Weber RG; Loeffler M;
    Genes Chromosomes Cancer; 2014 Jul; 53(7):589-605. PubMed ID: 24706357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
    Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells.
    Cox JL; Wilder PJ; Desler M; Rizzino A
    PLoS One; 2012; 7(8):e44087. PubMed ID: 22937156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accumulation of genomic aberrations during clinical progression of medulloblastoma.
    Korshunov A; Benner A; Remke M; Lichter P; von Deimling A; Pfister S
    Acta Neuropathol; 2008 Oct; 116(4):383-90. PubMed ID: 18704466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosomal characteristics of childhood brain tumors.
    Bigner SH; McLendon RE; Fuchs H; McKeever PE; Friedman HS
    Cancer Genet Cytogenet; 1997 Sep; 97(2):125-34. PubMed ID: 9283596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
    Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
    Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homozygous p53 gene mutation in a radiation-induced glioblastoma 10 years after treatment for an intracranial germ cell tumor: case report.
    Tada M; Sawamura Y; Abe H; Iggo R
    Neurosurgery; 1997 Feb; 40(2):393-6. PubMed ID: 9007876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma.
    Zhukova N; Ramaswamy V; Remke M; Martin DC; Castelo-Branco P; Zhang CH; Fraser M; Tse K; Poon R; Shih DJ; Baskin B; Ray PN; Bouffet E; Dirks P; von Bueren AO; Pfaff E; Korshunov A; Jones DT; Northcott PA; Kool M; Pugh TJ; Pomeroy SL; Cho YJ; Pietsch T; Gessi M; Rutkowski S; Bognár L; Cho BK; Eberhart CG; Conter CF; Fouladi M; French PJ; Grajkowska WA; Gupta N; Hauser P; Jabado N; Vasiljevic A; Jung S; Kim SK; Klekner A; Kumabe T; Lach B; Leonard JR; Liau LM; Massimi L; Pollack IF; Ra YS; Rubin JB; Van Meir EG; Wang KC; Weiss WA; Zitterbart K; Bristow RG; Alman B; Hawkins CE; Malkin D; Clifford SC; Pfister SM; Taylor MD; Tabori U
    Acta Neuropathol Commun; 2014 Dec; 2():174. PubMed ID: 25539912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.
    Kwon SM; Kang SH; Park CK; Jung S; Park ES; Lee JS; Kim SH; Woo HG
    PLoS One; 2015; 10(10):e0140528. PubMed ID: 26466313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.
    Neilsen BK; Sleightholm R; McComb R; Ramkissoon SH; Ross JS; Corona RJ; Miller VA; Cooke M; Aizenberg MR
    J Neurooncol; 2019 Mar; 142(1):111-118. PubMed ID: 30535594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
    Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
    J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of mutations in the AKT1 oncogene in glioblastomas and medulloblastomas.
    Schüller U; Ruiter M; Herms J; Kretzschmar HA; Grasbon-Frodl E
    Acta Neuropathol; 2008 Mar; 115(3):367-8. PubMed ID: 18172656
    [No Abstract]   [Full Text] [Related]  

  • 37. A simplified approach for molecular classification of glioblastomas (GBMs): experience from a tertiary care center in India.
    Purkait S; Mallick S; Sharma V; Kumar A; Pathak P; Jha P; Biswas A; Julka PK; Gupta D; Suri A; Upadhyay AD; Suri V; Sharma MC; Sarkar C
    Brain Tumor Pathol; 2016 Jul; 33(3):183-90. PubMed ID: 26865311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system.
    Burnett ME; White EC; Sih S; von Haken MS; Cogen PH
    Cancer Genet Cytogenet; 1997 Aug; 97(1):25-31. PubMed ID: 9242214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline MSH6 Mutation in a Patient With Two Independent Primary Glioblastomas.
    Forsström LM; Sumi K; Mäkinen MJ; Oh JE; Herva R; Kleihues P; Ohgaki H; Aaltonen LA
    J Neuropathol Exp Neurol; 2017 Oct; 76(10):848-853. PubMed ID: 28922847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glioblastoma multiforme in an Asian population: evidence for a distinct genetic pathway.
    Das A; Tan WL; Teo J; Smith DR
    J Neurooncol; 2002 Nov; 60(2):117-25. PubMed ID: 12635658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.